Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Tibet Rhodiola Pharmaceutical Holding Co.
  6. Summary
    600211   CNE000000ZW7

TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.

(600211)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
09/16/2021 09/17/2021 09/22/2021 09/23/2021 09/24/2021 Date
47.77 48.2 47.77 47.83 48.53 Last
2328024 2251116 1504200 1616981 2510267 Volume
-1.28% +0.90% -0.89% +0.13% +1.46% Change
Estimated financial data (e)
Sales 2019 1 256 M 194 M 194 M
Net income 2019 312 M 48,3 M 48,3 M
Net cash position 2019 830 M 128 M 128 M
P/E ratio 2019 18,3x
Yield 2019 3,31%
Sales 2020 1 373 M 212 M 212 M
Net income 2020 418 M 64,7 M 64,7 M
Net cash position 2020 773 M 120 M 120 M
P/E ratio 2020 39,8x
Yield 2020 0,76%
Capitalization 12 032 M 1 861 M 1 861 M
EV / Sales 2019 3,85x
EV / Sales 2020 11,6x
Nbr of Employees 476
Free-Float 38,6%
More Financials
Company
TIBET RHODIOLA PHARMACEUTICAL HOLDING CO. is a China-based company principally engaged in the production and distribution of pharmaceuticals. The Company operates its businesses through the distribution of proprietary drug products, as well as the processing of pharmaceuticals and others. The Company conducts its businesses primarily in South China, North China, East China, Central China and overseas markets. 
Sector
Pharmaceuticals
Calendar
10/22Earnings Release
More about the company
All news about TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.
09/20TIBET RHODIOLA PHARMACEUTICAL HOLDIN : 600211) added to S&P Global BMI Index
CI
08/16Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Half Year En..
CI
04/26Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the First Quarte..
CI
03/11Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Full Year En..
CI
01/04Stemirna COVID-19 vaccine candidate obtains clinical trial approval in China
RE
2020Fosun Pharma to buy 100 million doses of BioNTech's COVID-19 vaccine for mainland China
RE
2020Chinese Shares Slide on Potential US Sanctions; Tibet Rhodiola Falls 8%
MT
2020China's Rhodiola set to sell and test Russia's Sputnik-V vaccine
RE
2020Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Nine Months ..
CI
2020Tibet Rhodiola Pharmaceutical Holding Co. Approves the Proposal of Establishing Wholly-..
CI
2020Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Half Year En..
CI
2020Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the First Quarte..
CI
2020Tibet Rhodiola Pharmaceutical Holding Co. Declares Cash Dividend Per A Share for 2019, ..
CI
2020Tibet Rhodiola Pharmaceutical Holding Co. Reports Earnings Results for the Full Year En..
CI
2020Tibet Rhodiola Pharmaceutical Holding Co. Provides Earnings Guidance for the Year 2019
CI
More news
News in other languages on TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.

- No features available -

More news
Chart TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.
Duration : Period :
Tibet Rhodiola Pharmaceutical Holding Co. Technical Analysis Chart | 600211 | CNE000000ZW7 | MarketScreener
Technical analysis trends TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
Yuan Dong Guo General Manager & Director
Jun Chen Chief Financial Officer
Da Bin Chen Chairman
Pei Yao Chairman-Supervisory Board
Xue Cong Liu Independent Director
Sector and Competitors
1st jan.Capi. (M$)
TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.-27.87%1 861
JOHNSON & JOHNSON4.44%433 991
ROCHE HOLDING AG10.87%324 441
PFIZER, INC.20.05%247 760
NOVO NORDISK A/S51.58%233 750
ELI LILLY AND COMPANY37.22%210 490